"We embed research studies in the comfort and convenience of patient communities. By providing easy access to care, we help patients suffering from debilitating diseases now, while bringing hope for a cure for future generations."

During the past decade, Pivotal Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pivotal Research Center" #1 sponsor was "Cephalon" with 3 trials, followed by "Avanir Pharmaceuticals" with 1 trials sponsored, "Avera Pharmaceuticals" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pivotal Research Center" #1 collaborator was "Institute for the Study of Aging (ISOA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pivotal Research Center" are "Age-Related Memory Disorders" (2 trials), "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Anxiety Disorders" (2 trials) and "ADHD" (1 trials). Many other conditions were trialed in "Pivotal Research Center" in a lesser frequency.

Most popular intervention types in "Pivotal Research Center" are "Drug" (14 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "AV608" (1 trials), "DHA (nutritional supplement) or placebo" (1 trials), "GABITRIL (tiagabine hydrochloride; CEP-6671)" (1 trials), "Gabitril" (1 trials) and "Mifepristone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pivotal Research Center" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pivotal Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Pivotal Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pivotal Research Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".